ACKR1 | Atypical chemokine receptor 1 (Duffy blood group) | Blood group antigen proteins CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/16421/154116_A_9_11_selected_60x60.jpg) | ![](/images/17672/41563_B_8_2_rna_selected_60x60.jpg) | Mixed |
ACKR2 | Atypical chemokine receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13819/30339_B_2_3_rna_selected_60x60.jpg) | Tissue enriched |
ACKR3 | Atypical chemokine receptor 3 | Cancer-related genes G-protein coupled receptors Predicted membrane proteins
| ![](/images/49718/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/49718/116962_B_9_7_rna_selected_60x60.jpg) | Expressed in all |
ADRB1 | Adrenoceptor beta 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/67972/150140_A_4_8_selected_60x60.jpg) | ![](/images/67972/149849_A_9_5_rna_selected_60x60.jpg) | Tissue enhanced |
AGTR1 | Angiotensin II receptor, type 1 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/3596/ihc_cell_selected_60x60.jpg) | ![](/images/3596/11016_B_9_3_rna_selected_60x60.jpg) | Group enriched |
APLF | Aprataxin and PNKP like factor | Enzymes G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| ![](/images/34642/68665_B_6_1_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/34642/68664_B_8_1_rna_selected_60x60.jpg) | Mixed |
BAI2 | Brain-specific angiogenesis inhibitor 2 | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
C5AR1 | Complement component 5a receptor 1 | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| ![](/images/2720/ihc_selected_60x60.jpg) | | ![](/images/14520/ihc_cell_selected_60x60.jpg) | ![](/images/2720/6690_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
CASR | Calcium-sensing receptor | Disease related genes FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/39686/158078_A_4_8_selected_60x60.jpg) | ![](/images/50335/143981_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
CCR6 | Chemokine (C-C motif) receptor 6 | CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14488/33886_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
CCR7 | Chemokine (C-C motif) receptor 7 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/3796/11202_A_9_6_rna_selected_60x60.jpg) | Group enriched |
CD97 | CD97 molecule | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | ![](/images/13707/if_selected_60x60.jpg) | | ![](/images/13707/30523_B_8_6_rna_selected_60x60.jpg) | Expressed in all |
CELSR1 | Cadherin, EGF LAG seven-pass G-type receptor 1 | Disease related genes G-protein coupled receptors Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| ![](/images/67269/156096_B_5_7_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/67269/156091_A_1_4_rna_selected_60x60.jpg) | Mixed |
CHRM1 | Cholinergic receptor, muscarinic 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images/22366/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/14101/151887_B_8_1_rna_selected_60x60.jpg) | Group enriched |
CHRM3 | Cholinergic receptor, muscarinic 3 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images/24106/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/24106/52288_B_9_2_rna_selected_60x60.jpg) | Mixed |
CXCR2 | Chemokine (C-X-C motif) receptor 2 | Cancer-related genes CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/32017/139602_B_7_2_rna_selected_60x60.jpg) | Tissue enhanced |
CXCR3 | Chemokine (C-X-C motif) receptor 3 | CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45942/139631_B_7_6_rna_selected_60x60.jpg) | Tissue enhanced |
CXCR5 | Chemokine (C-X-C motif) receptor 5 | CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42432/123485_A_8_2_rna_selected_60x60.jpg) | Group enriched |
DRD5 | Dopamine receptor D5 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/48930/ihc_cell_selected_60x60.jpg) | ![](/images/48930/118540_B_9_2_rna_selected_60x60.jpg) | Group enriched |
EDNRA | Endothelin receptor type A | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images/13774/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/13774/33100_B_8_2_rna_selected_60x60.jpg) | Mixed |
ELTD1 | EGF, latrophilin and seven transmembrane domain containing 1 | G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | | ![](/images/25229/61162_A_3_1_rna_selected_60x60.jpg) | Mixed |
FZD1 | Frizzled class receptor 1 | Cancer-related genes G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| ![](/images/13008/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/13008/32446_B_9_1_rna_selected_60x60.jpg) | Mixed |
FZD10 | Frizzled class receptor 10 | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| ![](/images/14484/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/14484/34139_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
GABBR2 | Gamma-aminobutyric acid (GABA) B receptor, 2 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13820/142579_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
GLP2R | Glucagon-like peptide 2 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49244/122475_B_4_4_rna_selected_60x60.jpg) | Tissue enhanced |
GPR113 | G protein-coupled receptor 113 | G-protein coupled receptors Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/44500/98191_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
GPR123 | G protein-coupled receptor 123 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/42773/ihc_cell_selected_60x60.jpg) | ![](/images/42773/95049_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
GPR132 | G protein-coupled receptor 132 | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/29694/65145_B_9_3_rna_selected_60x60.jpg) | Mixed |
GPR135 | G protein-coupled receptor 135 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45337/103484_B_9_8_rna_selected_60x60.jpg) | Tissue enhanced |
GPR160 | G protein-coupled receptor 160 | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/6970/19466_B_8_2_rna_selected_60x60.jpg) | Mixed |
GPR162 | G protein-coupled receptor 162 | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images/55135/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/55135/130968_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
GPR182 | G protein-coupled receptor 182 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/27037/154241_A_1_7_selected_60x60.jpg) | ![](/images/27037/142398_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
GPR37L1 | G protein-coupled receptor 37 like 1 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/64454/153782_A_5_3_rna_selected_60x60.jpg) | Tissue enriched |
GPR61 | G protein-coupled receptor 61 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images/26088/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/26088/58703_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
GPRC5A | G protein-coupled receptor, class C, group 5, member A | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| ![](/images/7928/155465_A_7_5_selected_60x60.jpg) | | | ![](/images/7928/155464_B_6_4_rna_selected_60x60.jpg) | Tissue enhanced |
GPRC5B | G protein-coupled receptor, class C, group 5, member B | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| ![](/images/15247/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/15247/37196_A_1_7_rna_selected_60x60.jpg) | Tissue enhanced |
GRPR | Gastrin-releasing peptide receptor | G-protein coupled receptors Predicted membrane proteins
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
HCRTR2 | Hypocretin (orexin) receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/54516/ihc_cell_selected_60x60.jpg) | ![](/images/54516/127935_B_7_3_rna_selected_60x60.jpg) | Not detected |
HRH1 | Histamine receptor H1 | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| ![](/images/29740/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/29740/63005_B_9_5_rna_selected_60x60.jpg) | Mixed |
HTR2A | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14011/142185_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
KISS1R | KISS1 receptor | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins Transporters
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Not detected |
LPHN2 | Latrophilin 2 | G-protein coupled receptors Predicted membrane proteins
| ![](/images/13573/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/13573/39321_B_7_4_rna_selected_60x60.jpg) | Mixed |
MRGPRF | MAS-related GPR, member F | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Transporters
| ![](/images/28811/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/28811/60282_B_8_2_rna_selected_60x60.jpg) | Mixed |
NMBR | Neuromedin B receptor | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
NPFFR2 | Neuropeptide FF receptor 2 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| ![](/images/26825/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/26825/60867_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
NPSR1 | Neuropeptide S receptor 1 | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/7489/159226_A_1_5_rna_selected_60x60.jpg) | Tissue enhanced |
NTSR1 | Neurotensin receptor 1 (high affinity) | G-protein coupled receptors Predicted membrane proteins
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Not detected |
OPRM1 | Opioid receptor, mu 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/14509/ihc_cell_selected_60x60.jpg) | ![](/images/14509/34609_B_4_5_rna_selected_60x60.jpg) | Tissue enhanced |
P2RY12 | Purinergic receptor P2Y, G-protein coupled, 12 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14518/33943_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
P2RY13 | Purinergic receptor P2Y, G-protein coupled, 13 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49047/111260_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |